Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02880371
Title A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Array BioPharma
Indications

melanoma

stomach cancer

colorectal cancer

triple-receptor negative breast cancer

lung non-small cell carcinoma

urinary bladder cancer

head and neck squamous cell carcinoma

ovarian cancer

pancreatic ductal adenocarcinoma

Therapies

ARRY-382 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095 United States Details
UCLA Hematology/Oncology Los Angeles California 90095 United States Details
UCLA Hematology/Oncology - Santa Monica Santa Monica California 90404 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Hem-Onc Associates of Treasure Coast Port Saint Lucie Florida 34952 United States Details
Parkview Cancer Institute Fort Wayne Indiana 46845 United States Details
Parkview Regional Medical Center Fort Wayne Indiana 46845 United States Details
Parkview Research Center Fort Wayne Indiana 46845 United States Details
PPG Fort Wayne Indiana 46845 United States Details
Horizon Oncology Research, Inc. Lafayette Indiana 47905 United States Details
Hall-Perrine Cancer Center Laboratory Cedar Rapids Iowa 52403 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Labs - Rochester Superior Rochester Minnesota 55901 United States Details
Regions Cancer Care Center Saint Paul Minnesota 55101 United States Details
Regions Hospital Pharmacy Saint Paul Minnesota 55101 United States Details
Regions Hospital Saint Paul Minnesota 55101 United States Details
HealthPartners Neurosciences Center Saint Paul Minnesota 55130 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
The Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
UT Health Cancer Center San Antonio Texas 78229 United States Details
UTAH Cancer Specialists Salt Lake City Utah 84106 United States Details
ARUP Laboratories, Inc. Salt Lake City Utah 84108-1221 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22903 United States Details
UVA Health System Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field